Biotech Seed Investors & VC Firms

1754 firms in this list, with a median first check of $500K. 364 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
KA Karista ABBHCBED14 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Late Stage	$324K – $5.4M	+ Add to CRM
SA Safar Partners GSBMRMAC20 people	88🔒	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
PM PMV TB1 person · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	—	+ Add to CRM
TR Trendlines Group HBTDBSNK21 people	88🔒	Misgav	IL	Pre-Seed–Late Stage	$650K – $15M	+ Add to CRM
UT UTEC KM1 person · Follows rounds	88🔒	Tokyo	JP	Pre-Seed–Growth	$3.1M – $78M	+ Add to CRM
HO Hoxton Ventures BGMMPDRK16 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series B	$500K – $5M	+ Add to CRM
LA Launch NY GCMPCWLK4 people · Follows rounds	88🔒	Buffalo	US	Pre-Seed–Seed	$200K – $1M	+ Add to CRM
AM aMoon IDMMRSRW25 people	88🔒	Ra'anana	IL	Seed–Late Stage	—	+ Add to CRM
CL ClavystBio FAKSKLAT33 people	88🔒	Singapore	SG	Seed–Series A	—	+ Add to CRM
IM Impact Fund Denmark ADABAWAF36 people	88🔒	Copenhagen	DK	Seed–Late Stage	$2.2M – $70.2M	+ Add to CRM
RH Rho Ventures HKJRMLDR10 people	88🔒	New York	US	Pre-Seed–Late Stage	$2M – $15M	+ Add to CRM
AI AIX Ventures RSSJAGJM9 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$1M – $5M	+ Add to CRM
BI BioAdvance DSFJGHAG18 people · Leads rounds	88🔒	Conshohocken	US	Pre-Seed–Late Stage	$500K – $1.5M	+ Add to CRM
GO GoAhead Ventures CSPBTM3 people · Leads rounds	88🔒	Menlo Park	US	Pre-Seed–Series A	$500K – $1M	+ Add to CRM
FO FoodLabs CMPNFBTW22 people	88🔒	Berlin	DE	Pre-Seed–Series A	—	+ Add to CRM
NO Novartis Venture Fund AKBDFMLB25 people · Leads rounds	88🔒	Basel	CH	Pre-Seed–Late Stage	$5M – $25M	+ Add to CRM
BL Blue Revolution Investments G.P. CKGBWMCK30 people · Leads rounds	88🔒	Bergen	IE	Pre-Seed–Series A	—	+ Add to CRM
CE CEI Ventures CJNHSBBB18 people	88🔒	Brunswick	US	Seed–Late Stage	$1M – $4M	+ Add to CRM
EC EcoR1 Capital ONCSSMBZ17 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
EM Emles Venture Partners APFYJHJN14 people · Follows rounds	88🔒	New York	US	Pre-Seed–Seed	—	+ Add to CRM
EM EMV Capital IITHJCKD20 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series B	—	+ Add to CRM
MO Movac PMDBFFJG26 people · Leads rounds	88🔒	Auckland	NZ	Seed–Late Stage	$600K – $3M	+ Add to CRM
SO Solidus Investment	88🔒	Seoul	KR	Seed–Series A	—	+ Add to CRM
ME META Group AMADLAAM38 people	88🔒	Brussels	BE	Seed–Series A	—	+ Add to CRM

Karista

ParisPre-Seed–Late Stage$324K – $5.4M

ABBHCBED14 people

Safar Partners

CambridgePre-Seed–Late Stage

GSBMRMAC20 people

PMV

BrusselsPre-Seed–Late Stage

TB1 person

Trendlines Group

MisgavPre-Seed–Late Stage$650K – $15M

HBTDBSNK21 people

UTEC

TokyoPre-Seed–Growth$3.1M – $78M

KM1 person

Hoxton Ventures

LondonPre-Seed–Series B$500K – $5M

BGMMPDRK16 people

Launch NY

BuffaloPre-Seed–Seed$200K – $1M

GCMPCWLK4 people

aMoon

Ra'ananaSeed–Late Stage

IDMMRSRW25 people

ClavystBio

SingaporeSeed–Series A

FAKSKLAT33 people

Impact Fund Denmark

CopenhagenSeed–Late Stage$2.2M – $70.2M

ADABAWAF36 people

Rho Ventures

New YorkPre-Seed–Late Stage$2M – $15M

HKJRMLDR10 people

AIX Ventures

San FranciscoPre-Seed–Series A$1M – $5M

RSSJAGJM9 people

BioAdvance

ConshohockenPre-Seed–Late Stage$500K – $1.5M

DSFJGHAG18 people

GoAhead Ventures

Menlo ParkPre-Seed–Series A$500K – $1M

CSPBTM3 people

FoodLabs

BerlinPre-Seed–Series A

CMPNFBTW22 people

Novartis Venture Fund

BaselPre-Seed–Late Stage$5M – $25M

AKBDFMLB25 people

Blue Revolution Investments G.P.

BergenPre-Seed–Series A

CKGBWMCK30 people

CEI Ventures

BrunswickSeed–Late Stage$1M – $4M

CJNHSBBB18 people

EcoR1 Capital

San FranciscoSeed–Late Stage

ONCSSMBZ17 people

Emles Venture Partners

New YorkPre-Seed–Seed

APFYJHJN14 people

EMV Capital

LondonPre-Seed–Series B

IITHJCKD20 people

Movac

AucklandSeed–Late Stage$600K – $3M

PMDBFFJG26 people

Solidus Investment

SeoulSeed–Series A

META Group

BrusselsSeed–Series A

AMADLAAM38 people

Data sourced from public filings and firms' own websites — see our methodology.